Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anagenesis Biotechnologies - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12350
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solutions for varied cell type and research. Anagenesis Biotechnologies technology helps in generating paraxial mesoderm multipotent cells and differentiated muscle cells through recapitulation of every step in the embryonic and foetal myogenesis in vitro. The company also funds for developing applications in muscular dystrophies, myotonic disorders, spinal muscular atrophies, metabolic diseases of the muscle and other myopathies. Anagenesis Biotechnologies is headquartered in Strasbourg, France.

Anagenesis Biotechnologies – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Anagenesis Biotech Raises Funds through Venture Financing 10
Anagenesis Biotech Raises Funds through Venture Financing Round 11
Partnerships 12
Anagenesis Biotechnologies Enters into Research Agreement with Boehringer Ingelheim 12
Licensing Agreements 13
CRISPR Therapeutics Enters into Licensing Agreement with Anagenesis Biotechnologies 13
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 14
Anagenesis Biotechnologies – Key Competitors 15
Anagenesis Biotechnologies – Key Employees 16
Anagenesis Biotechnologies – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Key Facts 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagenesis Biotechnologies, Deals By Therapy Area, 2012 to YTD 2018 8
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anagenesis Biotech Raises Funds through Venture Financing 10
Anagenesis Biotech Raises Funds through Venture Financing Round 11
Anagenesis Biotechnologies Enters into Research Agreement with Boehringer Ingelheim 12
CRISPR Therapeutics Enters into Licensing Agreement with Anagenesis Biotechnologies 13
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 14
Anagenesis Biotechnologies, Key Competitors 15
Anagenesis Biotechnologies, Key Employees 16
Anagenesis Biotechnologies, Other Locations 17

List of Figures
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagenesis Biotechnologies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Anagenesis Biotechnologies:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orifarm Group AS:企業の戦略的SWOT分析
    Orifarm Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Brady Corporation:企業の戦略・SWOT・財務分析
    Brady Corporation - Strategy, SWOT and Corporate Finance Report Summary Brady Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Diagnostics For All Inc:企業の製品パイプライン分析2018
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tanabe Research Laboratories USA Inc (TRL), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a healthcare research center that discovers biological drugs. The center conducts research on metabolics, inflammation and immunology. Its products are used for the therapy of serious diseases with …
  • Genetic Analysis AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Israel Chemicals Ltd.:企業の戦略・SWOT・財務分析
    Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Companhia de Eletricidade do Estado da Bahia SA (CEEB5):企業の財務・戦略的SWOT分析
    Summary Companhia de Eletricidade do Estado da Bahia SA (COELBA) is a power distribution company that offers electricity services. The company's services include power supplying, electrical damage, shutdown consumer unit, load change, debts information, microgeneration connection and power minigener …
  • Australian Gas Networks Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Australian Gas Networks Ltd (Australian Gas Networks), formerly Envestra Ltd is an oil and gas company that distributes and transports natural gas. The company's services include managing the haulage of gas through each network, operation and maintenance of gas network, design an constructio …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Central Electricity Generating Co:発電所・企業SWOT分析
    Central Electricity Generating Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Trimble Inc (TRMB):企業の財務・戦略的SWOT分析
    Trimble Inc (TRMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dixons Carphone plc:企業のM&A・事業提携・投資動向
    Dixons Carphone plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dixons Carphone plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • NanoString Technologies Inc (NSTG)-製薬・医療分野:企業M&A・提携分析
    Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, ge …
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Proteus Digital Health Inc (Proteus) is a digital medicine company that develops and sells medicines for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medi …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆